ArticleMedical journal of the Islamic Republic of Iran2025
Complications of CT-Guided Percutaneous Lung Biopsy: A 1-Year Single-Center Experience in Iran.
Article in Medical journal of the Islamic Republic of Iran, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite observing all precautions, complications are not uncommon during transthoracic needle biopsy (TTNB). We aimed to evaluate the complications associated with TTNB in patients with lung masses from 1 center in southern Iran. Methods: In this retrospective cohort study, data on complication rates, types, and potential risk factors from 87 biopsies were collected. Complications were assessed through immediate post-biopsy computed tomography (CT) scans and follow-up chest X-rays, and their correlations were evaluated with patient demographics, lesion characteristics, and procedural factors. Chi-square and Wilcoxon rank-sum tests were used for univariable analysis, and multivariable binary logistic regression analyses were conducted to control for potential confounders. Results: The overall complication rate was 37.9% (95% CI, 27.6%-48.3%), with pneumothorax being the most common, occurring in 26.4% (95% CI, 17.3%-35.6%) of cases, followed by perilesional hemorrhage (17.2%) (95% CI, 10.3%-25.3%), hemoptysis (3.3%), and pleural effusion (1.1%). All pneumothorax cases were identified via immediate post-biopsy CT, and only 1 patient required chest tube insertion. No significant correlations were found between age, sex, presence of emphysema, lesion size, location, and depth, or needle path and the incidence of pneumothorax. However, a significantly higher perilesional hemorrhage incidence was observed for smaller lesion size (26 mm [interquartile range, IQR], 13,40 vs 43 mm [IQR, 24,73]; Conclusion: TTNB is generally safe, with a manageable complication profile. Early detection and appropriate follow-up are crucial, particularly for pneumothorax, which often resolves spontaneously. The findings underscore the importance of considering lesion characteristics to minimize complications during biopsy procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.